Parameters | Healthy controls (n = 27) | Patients with ASD | |||||
---|---|---|---|---|---|---|---|
Detection limit | Group I (n = 62) | р1* | Group II (n = 71) | р1* | р2** | ||
cfDNA, ng/ml | 25 ng/ml | 389.4 ± 26 (151.8–732.6) | 512.9 ± 197.8 (115.0–11338.0) | 0.014 | 1151.2 ± 175.7 (78.7–4692.3) | < 0.001 | < 0.001 |
Nuclease activity, U/ml | 1 U/ml | 8.6 ± 1.1 (3.3–29.2) | 9.9 ± 1.0 (1.8–33.6) | 0.599 | 10.4 ± 0.7 (4.4–30.7) | 0.089 | 0.271 |
8-oxodG/106 deoxynucleosides | 0.5/106deoxynucleosides | 4.8 ± 0.9 (0.6–20.6) | 3.3 ± 0.6 (0.5–20.6) | 0.107 | 638.3 ± 313.2 (0.8–10478.9) | < 0.001 | < 0.001 |